Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Jacobs SA, Wang Y, Abraham J, Feng H, Montero AJ, Lipchik C, Finnigan M, Jankowitz RC, Salkeni MA, Maley SK, Puhalla SL, Piette F, Quinn K, Chang K, Nagy RJ, Allegra CJ, Vehec K, Wolmark N, Lucas PC, Srinivasan A, Pogue-Geile KL. Jacobs SA, et al. Among authors: jankowitz rc. Breast Cancer Res. 2024 May 24;26(1):83. doi: 10.1186/s13058-024-01833-6. Breast Cancer Res. 2024. PMID: 38790033 Free PMC article. No abstract available.
Epigenetics in breast cancer: what's new?
Huang Y, Nayak S, Jankowitz R, Davidson NE, Oesterreich S. Huang Y, et al. Breast Cancer Res. 2011;13(6):225. doi: 10.1186/bcr2925. Epub 2011 Nov 1. Breast Cancer Res. 2011. PMID: 22078060 Free PMC article. Review.
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I study.
Jankowitz RC, Abraham J, Tan AR, Limentani SA, Tierno MB, Adamson LM, Buyse M, Wolmark N, Jacobs SA. Jankowitz RC, et al. Cancer Chemother Pharmacol. 2013 Dec;72(6):1205-12. doi: 10.1007/s00280-013-2262-2. Cancer Chemother Pharmacol. 2013. PMID: 24077916 Clinical Trial.
Should we embrace or ablate our urge to (ovarian) suppress?
Jankowitz RC, Puhalla S, Davidson NE. Jankowitz RC, et al. J Clin Oncol. 2014 Dec 10;32(35):3920-2. doi: 10.1200/JCO.2014.57.9953. Epub 2014 Nov 3. J Clin Oncol. 2014. PMID: 25366692 No abstract available.
Molecular drivers of lobular carcinoma in situ.
Logan GJ, Dabbs DJ, Lucas PC, Jankowitz RC, Brown DD, Clark BZ, Oesterreich S, McAuliffe PF. Logan GJ, et al. Among authors: jankowitz rc. Breast Cancer Res. 2015 Jun 4;17:76. doi: 10.1186/s13058-015-0580-5. Breast Cancer Res. 2015. PMID: 26041550 Free PMC article. Review.
73 results